Lose G, Jespersen J, Frandsen B, Højensgård JC, Astrup T. Subcutaneous heparin in the treatment of interstitial cystitis.
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY 1985;
19:27-9. [PMID:
4023647 DOI:
10.3109/00365598509180218]
[Citation(s) in RCA: 30] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
Chronic interstitial cystitis (IC) is an inflammatory condition of the bladder of unknown aetiology. Clinically, IC is difficult to handle. Previously, we reported that administration of subcutaneous heparin has an immediate, ameliorating effect. We have now followed eight of the patients for one year or more, during which period they received subcutaneous heparin in doses varying from 5000 IU per day to 5000 IU 2-3 times a week. This treatment was found to have a long-term beneficial effect. No side effects were observed.
Collapse